Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Authors' reply.

Elder NM, Atayee RS, Best BM, Ma JD.

J Anal Toxicol. 2014 Sep;38(7):463. doi: 10.1093/jat/bku074. Epub 2014 Jul 1. No abstract available.

PMID:
24986838
2.

Uncertainty in assessing impact of drug-drug interactions on oxycodone metabolite patterns.

DePriest AZ, Puet BL, Heltsley R, Robert T, Black DL.

J Anal Toxicol. 2014 Sep;38(7):462. doi: 10.1093/jat/bku071. Epub 2014 Jul 1. No abstract available.

PMID:
24986837
3.

Urine drug testing for oxycodone and its metabolites as a tool for drug-drug interactions?

Mikus G.

J Anal Toxicol. 2015 Jan-Feb;39(1):81-2. doi: 10.1093/jat/bku111. Epub 2014 Oct 6. No abstract available.

PMID:
25288721
4.

Response to urine drug testing for oxycodone and its metabolites as a tool for drug-drug interactions.

Elder NM, Atayee RS, Best BM, Ma JD.

J Anal Toxicol. 2015 Jan-Feb;39(1):80. doi: 10.1093/jat/bku112. Epub 2014 Oct 6. No abstract available.

PMID:
25288719
5.

Observations of urinary oxycodone and metabolite distributions in pain patients.

Elder NM, Atayee RS, Best BM, Ma JD.

J Anal Toxicol. 2014 Apr;38(3):129-34. doi: 10.1093/jat/bku007. Epub 2014 Feb 11.

PMID:
24523296
6.

Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients.

Yee DA, Best BM, Atayee RS, Pesce AJ.

J Anal Toxicol. 2012 May;36(4):232-8. doi: 10.1093/jat/bks022.

PMID:
22511697
7.

Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.

Cone EJ, Zichterman A, Heltsley R, Black DL, Cawthon B, Robert T, Moser F, Caplan YH.

Forensic Sci Int. 2010 May 20;198(1-3):58-61. doi: 10.1016/j.forsciint.2009.12.005. Epub 2009 Dec 29.

PMID:
20036472
8.

Tentative identification of novel oxycodone metabolites in human urine.

Moore KA, Ramcharitar V, Levine B, Fowler D.

J Anal Toxicol. 2003 Sep;27(6):346-52.

PMID:
14516487
9.
10.

Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration.

DePriest AZ, Heltsley R, Black DL, Mitchell JM, LoDico C, Flegel R, Cone EJ.

J Anal Toxicol. 2016 Oct;40(8):566-574. Epub 2016 Jul 11.

PMID:
27405370
11.

Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.

Cone EJ, Heltsley R, Black DL, Mitchell JM, Lodico CP, Flegel RR.

J Anal Toxicol. 2013 Jun;37(5):255-64. doi: 10.1093/jat/bkt031. Epub 2013 Apr 21.

PMID:
23609023
12.

Monitoring oxycodone use in patients with chronic pain: analysis of oxycodone and metabolite excretion in saliva and urine.

Moy KV, Ma JD, Morello CM, Atayee RS, Best BM.

J Opioid Manag. 2014 Jan-Feb;10(1):47-56. doi: 10.5055/jom.2014.0191.

PMID:
24604569
13.

The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation.

Kirvela M, Lindgren L, Seppala T, Olkkola KT.

J Clin Anesth. 1996 Feb;8(1):13-8.

PMID:
8695073
14.

Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites.

French D, Wu A, Lynch K.

Bioanalysis. 2011 Dec;3(23):2603-12. doi: 10.4155/bio.11.266.

PMID:
22136049
15.

Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients.

Naito T, Tashiro M, Ishida T, Ohnishi K, Kawakami J.

J Clin Pharmacol. 2013 Aug;53(8):812-8. doi: 10.1002/jcph.112. Epub 2013 Jun 3.

PMID:
23733622
16.
17.

Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.

Lemberg KK, Kontinen VK, Siiskonen AO, Viljakka KM, Yli-Kauhaluoma JT, Korpi ER, Kalso EA.

Anesthesiology. 2006 Oct;105(4):801-12.

PMID:
17006080
18.

Is it time to drug test your chronic pain patient?

McBane S, Weigle N.

J Fam Pract. 2010 Nov;59(11):628-33. No abstract available.

PMID:
21060901
19.

Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain.

Hao GT, Zhou HY, Gao HZ, Qu HY, Liang YG, Li YY, Dong RH, Zhang LJ, Wang XF, Liu ZY.

Pharmacol Rep. 2014 Feb;66(1):153-8. doi: 10.1016/j.pharep.2013.08.012. Epub 2014 Feb 1.

PMID:
24905321
20.

Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.

Heltsley R, Zichterman A, Black DL, Cawthon B, Robert T, Moser F, Caplan YH, Cone EJ.

J Anal Toxicol. 2010 Jan-Feb;34(1):32-8.

PMID:
20109300

Supplemental Content

Support Center